Harfst & Associates, Inc. Amgen Inc Transaction History

Harfst & Associates, Inc.

$444 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 01, 2024	BUY	$268.87 - $324.56 $189,553 - $228,814	705 New	705 $200,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $38,355 - $43,269	-150 Reduced 17.2%	722 $207,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $190,662 - $236,713	872 New	872 $234,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $4,741 - $5,779	-21 Reduced 0.84%	2,482 $600,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $10,764 - $13,677	-47 Reduced 1.84%	2,503 $657,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $2,768 - $3,080	-12 Reduced 0.47%	2,550 $620,000
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $66,658 - $73,741	304 Added 13.46%	2,562 $619,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $10,938 - $12,518	55 Added 2.5%	2,258 $507,000
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $3,396 - $3,979	16 Added 0.73%	2,203 $468,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $305,522 - $338,955	-1,308 Reduced 37.42%	2,187 $533,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $221,022 - $257,565	996 Added 39.86%	3,495 $869,000
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $254,246 - $302,762	1,175 Added 88.75%	2,499 $574,000
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $11,028 - $12,264	47 Added 3.68%	1,324 $336,000
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $708,357 - $869,251	-3,581 Reduced 73.71%	1,277 $301,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $34,261 - $45,439	188 Added 4.03%	4,858 $984,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $15,136 - $19,456	80 Added 1.74%	4,670 $1.13 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $46,487 - $55,701	267 Added 6.18%	4,590 $888,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $49,009 - $57,450	294 Added 7.3%	4,323 $796,000
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $94,956 - $107,037	525 Added 14.98%	4,029 $765,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $40,496 - $47,272	227 Added 6.93%	3,504 $682,000
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $23,346 - $26,320	126 Added 4.0%	3,277 $679,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $23,911 - $26,857	144 Added 4.79%	3,151 $581,000
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $22,195 - $25,938	131 Added 4.55%	3,007 $512,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $9,621 - $10,749	57 Added 2.02%	2,876 $500,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $2,007 - $2,292	12 Added 0.43%	2,819 $525,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,807	2,807 $483,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.

Account